Penn Vet Cardiology is currently seeking dogs with stable untreated mitral valve disease.

The purpose of the study is to test the tolerability and short term (6 hour) effects of a new investigational drug that we believe can help delay progression of disease.

The study involves a one-day hospital visit during which your dog will be given two subcutaneous injections of the new drug. 

We will monitor blood pressure and various blood and urine parameters to help determine if the drug promotes favorable effects on fluid retention, which is a feature of mitral valve disease.

Eligibility Criteria:  

  • Dogs with stable untreated mitral valve disease.


  • Owners get a $50 gift card for participating

What the trial covers:

  • The study covers all study procedures and day hospitalization.



Mark A Oyama, DVM DACVIM-Cardiology,
Professor and Chief of Cardiology at Penn Vet's Ryan Hospital
phone: 215-898-2964 (office)